Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
36.70
+1.71 (4.89%)
At close: Jun 26, 2026, 4:00 PM EDT
37.32
+0.62 (1.69%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.87 billion as of June 26, 2026. Its market cap has increased by 27.77% in one year.
Market Cap
3.87B
Enterprise Value
2.63B
1-Year Change
27.77%
Ranking
Category
Stock Price
$36.70
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.87B, an increase of 586.20%. That is a compound annual growth rate of 27.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 3.87B | -12.40% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 4.11B |
| Viking Therapeutics | 4.04B |
| Definium Therapeutics | 3.95B |
| Denali Therapeutics | 3.93B |
| ACADIA Pharmaceuticals | 3.87B |
| Catalyst Pharmaceuticals | 3.84B |
| Relay Therapeutics | 3.80B |
| Telix Pharmaceuticals | 3.70B |